U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes 
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
HKEX’s Permissive IPO Rules Could Open Opportunities for Korea to Strengthen Its Position in International Listings 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core 
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
SANTA BARBARA, Calif., April 27, 2017 -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its first quarter 2017 financial results on Tuesday, May 9, 2017 after market close.
Sientra will hold a conference call on Tuesday, May 9, 2017 at 1:30 p.m. PT/4:30 p.m. ET to discuss the results. A press release disclosing the Company's financial results will be distributed at approximately 1:00 p.m. PT/4:00 p.m. ET that same day.
The dial-in numbers are (844) 464-3933 for domestic callers and (765) 507-2612 for international callers. The conference ID is 15029000. A live webcast of the conference call will be available on the Investor Relations section of the Company's website at www.sientra.com.
A replay of the call will be available starting on May 9, 2017 at 4:30 p.m. PT/7:30 p.m. ET, through May 10, 2017 at 8:59 p.m. PT/11:59 p.m. ET. To access the replay, dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers, and use the replay conference ID 15029000. The webcast will be available on the Investor Relations section of the Company’s website for 30 days following the completion of the call.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including bioCorneum®, the professional choice in scar management.
Investor Contacts: The Ruth Group Nick Laudico / Brian Johnston (646) 536-7030 / (646) 536-7028 [email protected]
